UCB

UCB is a biopharmaceutical company that focuses on creating value for people who are living with severe diseases in immunology and neurology now and in the future.

The company works with stakeholders to address unmet needs of patients and caregivers, helping them to attain their goals and live the lives they want.

UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives, while creating value for society. The company's commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how that are required to serve patients in need.

UCB focuses on neurology and immunology disorders by putting patients at the center of its world. UCB is continuously working to advance science and embrace new knowledge and it is leveraging scientific advances and skills in areas such as genetics, biomarkers and human biology.

Scientists at UCB collaborate with leading researchers from the industry and academia to advance science and offer the solutions that patients need.